ThermoGenesis (NASDAQ: THMO) Prepares Launch of ReadyStart cGMP Suites for Cell & Gene Therapy Companies
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) is engaged as an industry leader in automated cell processing tools and services for cell ...
Wednesday, March 22, 2023
Tag: cell therapy
Cellect Biotechnology, Ltd. (NASDAQ: APOP) Reports the First ApoGraft Bone Marrow Transplant in U.S. Patient
Cellect Biotechnology, Ltd. (NASDAQ: APOP) is an Israeli biotechnology company that is focused on the research and development of cell ...
Enochian Biosciences, Inc. (NASDAQ: ENOB) Jumps 107% After FDA Accepts Pre-IND Request for its Potential HIV Break-Through Treatment
Enochian Biosciences, Inc. (NASDAQ: ENOB) is engaged as a biopharmaceutical company, which is focused on the research, development, manufacturing, and ...
Avalon GloboCare Corp. (NASDAQ: AVCO) Prepares Commercialization Launch of its ACTEX Platform As Global Regenerative Therapeutics Outlook Looks Robust
Cells are the building blocks of life. Scientists estimate that the average human body is comprised of around 37.2 trillion ...
Fibrocell Science, Inc. (NASDAQ: FCSC) Jumps 49% After Announcing Collaboration with Castle Creek Pharmaceuticals to Further Develop, Commercialize FCX-007 Treatment
Fibrocell Science, Inc. (NASDAQ: FCSC) operates as a cell and gene therapeutics company, which focuses on the research, development, and ...
Immusoft Corporation Closes Series B Financing After Raising $20 Million
Immusoft Corporation is a Seattle-based cell therapy company that looks to treat diseases through its Immune System Programming (ISP) platform. ...
